Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of an Adjusted Calculation Model Regarding Heparin and Protamine Dosing on Bleeding and Transfusions After Cardiac Surgery Compared With Standard Dosing: A Randomized Single Blind Trial

NCT02785575 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT02785575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02785575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of an Adjusted Calculation Model Regarding Heparin and Protamine Dosing on Bleeding and Transfusions After Cardiac Surgery Compared With Standard Dosing: A Randomized Single Blind Trial
Lead sponsor
Karolinska University Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2016
Completion date
February 28, 2018
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, cardiac surgery, heparin, protamine sulfate, transfusion